Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease

Caroline L. Benn, Rachel Butler, Lydia Mariner et al. · 2009

Read Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease by Caroline L. Benn, Rachel Butler, Lydia Mariner et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005747.txt.

Description

Caroline Benn and co-authors tested in 2009 whether lowering one gene's activity eases Huntington's disease in mice. Huntington's is a fatal inherited brain disease with no treatment that slows it. Faulty gene control inside cells is part of the damage, so enzymes that tune genes are drug targets.

The team reduced HDAC7, one such tuning enzyme, in the R6/2 mouse model. The disease course did not improve. A clear negative result still guides the field: effort can shift to other HDAC types. The study shows why each candidate must be tested alone, not assumed to help as a class.

Catalog record

CREATORCaroline L. Benn, Rachel Butler, Lydia Mariner et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005747

Browse the full library · About the Tower of Babel